Browse diseases

…ngly recognised as a prognostic marker in oncology. Its role in breast cancer and its variation across molecular subtypes remains unclear. Th…

…x AL, Effi C, Dozmorov MG.,Bos, P.D. Regulatory T Cells Support Breast Cancer Progression by Opposing IFN-gamma-Dependent Functional Reprogra…

… responses, but they have proved ineffective against metastatic breast cancer as single-agent therapies. Myeloid cell-T cell interactions con…

…to 20 times greater effectiveness in HER2-moderate and HER2-low breast cancer cell lines. In the bystander killing assay, TPE inhibited the p…

…synthesises the application of patient journey mapping (PJM) in breast cancer care to provide insights for enhancing patient-centred services…

…ested to undertake an expedited update of its 2018 guideline on breast cancer screening. The request was triggered by the release of the Unit…

… barriers to timely diagnosis among Iranian women with advanced breast cancer. Data analysis were performed using MAXQDA software, V.20.Parti…

… status (SES) strata experience disproportionately low rates of breast cancer screening, contributing to delayed diagnoses and poorer prognos…

…Introduction Breast cancer is a leading cause of cancer-related death among women. Women w…

…netrance, similar to other pathogenic variants in moderate risk breast cancer genes such as ATM and CHEK2. We also provide risk-adapted recom…

…ling around risk of hormone replacement therapy(HRT)-associated breast cancer and screening pathways, with limited data suggesting screening …

…ckground Progesterone is critical for cyclic breast changes and breast cancer carcinogenesis. The commercially available progesterone recepto…